Medtech industry's uptake of 3-D printing catches eye of US FDA
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is to explore whether it will need to develop guidelines and standards to cover the fast-growing medical device manufacturing technique of additive manufacturing, often referred to as 3–D printing1.